drugset / Trial / NCT02162875

Schistosoma Mansoni in Mwanza Region, Tanzania

NCT02162875

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to determine the strategy for mass drug administration (MDA) which provides the greatest reductions in prevalence and intensity of Schistosoma mansoni in school-aged children after 4 years of intervention.

Timeline

Start
2011-03
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Praziquantel Small molecule 40 mg/kg